The health care industry continues to evolve, and payers remain focused on achieving their triple aim targets through the shift to value-based care. Industry-leading labs are in a unique position to support this evolution given their data, operations infrastructure, and diagnostics expertise.
This webinar will give participants a view into value-based care innovations in the lab industry and how payers can collaborate with their top labs on a variety of value-based programs, bringing the same aligned incentives and enhanced patient experience to lab services as exist today in other areas of the industry.
Vice President, Health Plans
Al Bowles is the Vice President, Health Plans, at Quest Diagnostics and is responsible for leading the health plan business within Quest. Al has been in the U.S. employee benefits/healthcare industry for over 30 years, holding several leadership positions at Cigna, UnitedHealthcare, and Horizon BCBSNJ. Prior to joining Quest, Al was Vice President of Commercial & Major Accounts at Horizon BCBSNJ, with responsibility for 1.8 million members. Prior to that role, Al served as the Chief Marketing Officer for Optum Specialty Benefits, a UnitedHealth Group company. At Cigna, Al held regional and national roles including the Senior Vice President of Sales for CIGNA Group Insurance. Al earned a BS degree from the University of Richmond as well as completed an executive leadership program at the Wharton School.
Cathi Rubin Franklin, MS, LCGC
Senior Manager, Genomic Services
Cathi Rubin Franklin is Senior Manager, Genomic Services, at Quest Diagnostics and is a genetic counselor who is board-certified by the American Board of Medical Genetics and the American Board of Genetic Counseling. At Quest, she trains and directs the genomic client service specialists and the genomic coordinator teams who support Quest’s internal and external genetics customers. Cathi joined Quest Diagnostics in 1995. Her areas of special interest include molecular genetics with an emphasis on the hemoglobinopathies. Additionally, Cathi has a strong interest in and has been integrally involved in test utilization management at Quest as well as within the genetics community.